Equities Research Analysts’ ratings reiterations for Monday, November 16th:
Anika Therapeutics (NASDAQ:ANIK) had its buy rating reissued by analysts at B. Riley Financial. They currently have a $17.00 target price on the stock, down from their previous target price of $23.00.
Annovis Bio (NYSE:ANVS) had its buy rating reiterated by analysts at Roth Capital. Roth Capital currently has a $3.00 price target on the stock.
APN Resources (LON:APN) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 370 target price on the stock.
APN Resources (LON:APN) had its buy rating reiterated by analysts at Canaccord Genuity Group. Canaccord Genuity Group currently has a GBX 365 target price on the stock.
ASOS (LON:ASC) had its buy rating reissued by analysts at Shore Capital Group. They currently have a GBX 520 price target on the stock.
Codexis (NASDAQ:CDXS) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $5.00 target price on the stock.
Coats Group (LON:COA) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 135 target price on the stock.
Copart (NASDAQ:CPRT) had its equal weight rating reissued by analysts at Stephens. The firm currently has a $35.00 price target on the stock.
CleanTech Lithium (LON:CTL) had its speculative buy rating reissued by analysts at Canaccord Genuity Group. They currently have a GBX 15 price target on the stock.
CareTrust REIT (NYSE:CTRE) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $44.00 price target on the stock.
CommVault Systems (NASDAQ:CVLT) had its overweight rating reissued by analysts at Stephens. They currently have a $205.00 target price on the stock.
Ceres Power (LON:CWR) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 950 price target on the stock.
DeFi Technologies (NASDAQ:DEFT) had its buy rating reissued by analysts at B. Riley Financial. B. Riley Financial currently has a $0.64 target price on the stock, up from their previous target price of $0.62.
Adherex Technologies (NASDAQ:FENC) had its buy rating reissued by analysts at B. Riley Financial. B. Riley Financial currently has a $19.00 target price on the stock, up from their previous target price of $18.00.
Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $60.00 price target on the stock.
Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $56.00 price target on the stock.
Hasbro (NASDAQ:HAS) had its buy rating reissued by analysts at Roth Capital. The firm currently has a $136.00 target price on the stock, up from their previous target price of $125.00.
Intermediate Capital Group (LON:ICG) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 2,640 price target on the stock.
Land Securities Group (LON:LAND) had its buy rating reaffirmed by analysts at Deutsche Bank. The firm currently has a GBX 750 price target on the stock.
Maestrano Group (LON:MNO) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 183 price target on the stock.
NIKE (NYSE:NKE) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $38.00 price target on the stock.
Oxford Nanopore Technologies (LON:ONT) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a GBX 300 target price on the stock.
Palo Alto Networks (NASDAQ:PANW) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $425.00 target price on the stock.
Palo Alto Networks (NASDAQ:PANW) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $440.00 target price on the stock.
Premier Foods (LON:PFD) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 290 price target on the stock.
Precigen (NASDAQ:PGEN) had its buy rating reiterated by analysts at B. Riley Financial. The firm currently has a $11.00 target price on the stock, down from their previous target price of $12.00.
Prime Medicine (NASDAQ:PRME) had its buy rating reissued by analysts at HC Wainwright. They currently have a $8.00 price target on the stock.
SpaceX (NASDAQ:SPCX) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $225.00 target price on the stock.
Sirius Real Estate (LON:SRE) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 134 price target on the stock.
VersaBank (NASDAQ:VBNK) had its buy rating reaffirmed by analysts at Roth Capital. Roth Capital currently has a $32.00 price target on the stock, up from their previous price target of $28.00.
Wise (LON:WISE) had its buy rating reissued by analysts at Canaccord Genuity Group. They currently have a GBX 1,171 price target on the stock.
Receive News & Ratings for Anika Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
